Compound Azintamide Enteric-coated Tablets, Pancreatin supplement with simethicone, effectively promote choleretic, quickly eliminate abdominal distension, effectively relieve indigestion symptoms such as loss of appetite, abdominal discomfort, early satiety, belching, fatty stool, chemical indigestion, etc.

CSL Behring is one of the largest import suppliers in China's human albumin market. Baheal has collaborated with CSL Behring since 2018 and remains a key partner for CSL Behring in China. Human albumin is a life-saving product primarily used to treat shock caused by hemorrhagic trauma or burns, as well as for the prevention and treatment of hypoalbuminemia. Due to factors such as stringent market regulation, increased clinical demand, and limited plasma supply, China's human albumin market has consistently faced a supply shortage.

An US dietary supplements brand, specialized in the development and production of natural, organic, and high-potency dietary supplements.

Micro-needle eye mask, applying the "transdermal drug delivery technology” originated from a key invention of a Japanese medical laboratory, enabling users to have medical-level care at home. Medical evidence shows safe and effective release of worries about trauma, pain, escharotic and reconstruction. With simple ingredients, high efficacy and 40+ patents, it effectively relieves the symptoms of dark circles, fine lines around the eyes, etc.

Bi Bai Ke originates from the Qing Dynasty imperial prescription “Wan Ying Ding,” a formula for clearing heat and detoxifying the body. It uses natural bear bile powder as its primary ingredient, with each tablet containing 11.1mg of bear bile powder. It is formulated with authentic herbs such as wine-processed rhubarb and Coptis chinensis, following a rigorous and well-balanced formulation. It is specifically used for various symptoms of “heat” in the body, offering unique therapeutic effects.

ZAP Surgical specializes in precision brain radiotherapy and has pioneered a dedicated robotic radiosurgery system for intracranial and head & neck tumors and lesions. Its innovative technology delivers precise, efficient, and safe stereotactic radiosurgery to patients worldwide. The system has obtained market approval in 26 countries and regions, including China, and has completed over 5,000 clinical treatments.

Huake Pioneer focuses on providing radiation therapy solutions for patients with whole-body tumors and arrhythmias with the top-tier medical linear accelerators. Based on the global leading 4π radiotherapy technology, the company is guided by clinical requirements to develop world-class medical linear accelerators and associated software for the treatment of cancer and various illnesses.

Based on State Key Laboratory of Cardiovascular Disease, Baheal Guoxin is committed to the R&D of breakthrough technologies and achievement transformation platform for Cardiovascular Medical Devices. With the non-invasive radiotherapy system for arrhythmia as its core breakthrough, the enterprise innovatively integrates radiotherapy with cardiac electrophysiology to transform its treatment methods from invasive surgery to precise and non-invasive therapies, to drive a technological revolution in cardiovascular diseases treatment.

Enrolled in China National Reimbursement Drug List (NRDL) category B list, level I medical evidence. First anti-hepatic fibrosis therapeutic drug recommended in six Major Guidelines or Consensuses. First FDA Phase II clinical trial completed Chinese proprietary therapeutic drug for hepatopathy. Substantial clinical evidence shows the efficacy of preventing and treating hepatic fibrosis, liver cirrhosis.

Utidelone Injection is a tumor chemotherapy drug and a Class I innovative drug developed by Huahai Zhongtian (China's first publicly listed synthetic biology pharmaceutical company). (First approved indication) It is indicated for the treatment of recurrent or metastatic advanced breast cancer. Compared to taxane drugs, it offers superior safety, enhanced efficacy, reduced susceptibility to drug resistance, and the ability to cross the blood-brain barrier.

JiKun Medicine is an innovation-powered drug discover and development company, focusing on developing new drugs and therapeutic approaches against organ fibrosis. JiKun has the most mature innovative anti-fibrotic drug screening and evaluation platform in China and has established a complete research and development system spanning from target discovery to clinical development, with multiple self-innovated anti-fibrotic drugs entering the clinical stage.

RabPharma is a pioneering research and development platform in the medical sector, focusing on challenging orthopedic conditions. Motivated by the unmet medical needs both in China and globally, the company is developing original therapeutics with first-in-class or best-in-class potential.

JI LUN TAI is committed to providing comprehensive solutions for nuclear medicine molecular imaging diagnosis and treatment. We focus on the research and development of top-level radioactive drugs with independent intellectual property rights in global scale, driving equipment innovation along with drug innovation. Our pipeline covers multiple fields including SPECT diagnostic medicines, PET diagnostic medicines, targeted therapeutic drugs and imaging equipment.

Baheal Wisart focuses on cutting-edge technologies transformation and innovative medicines R&D of the cardiovascular diseases. It possesses internationally leading technologies for the preservation, isolation, cultivation and cryopreservation of human primary cardiomyocytes. Based on State Key Laboratory of Cardiovascular Disease, Baheal Wisart is fully committed to the R&D and translation of cardiovascular diseases innovative medicines, effectively serving the national strategic needs for the prevention and treatment of cardiovascular diseases.